Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.098 | 0.7 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |